Lymphoma (includes NHL, HL, CNS Lymphoma)
Featured Articles
(Los Angeles Times) Oct 19, 2017 - Gilead Sciences Inc.’s stock rose Thursday after the biotech company’s Kite Pharma unit gained federal approval for its flagship cell-treatment therapy for adults with advanced lymphoma.
Read Article
(Washington Post/To Your Health) Oct 18, 2017 - The Food and Drug Administration approved a second version of a groundbreaking treatment Wednesday that genetically alters patients' cells to attack cancer — this time, to fight aggressive non-Hodgkin lymphoma.
Read Article
Latest Articles
October 19, 2017
October 19, 2017
October 19, 2017
October 18, 2017
October 13, 2017
October 13, 2017
October 13, 2017
October 12, 2017
View More
News Commentary
Editor Image
05 Oct, 2017 | by Dean Gesme, MD
An excellent editorial this past week in JCO authored by Jim Armitage and Dan...
View Comment
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
Introduction In an effort to provide you with timely market feedback from the 58th ASH Annual Meeting held in December... Read more
January 06, 2017
By: Greg Wolfe, Ph.D., Senior Consultant, Clinical & Scientific Assessment, Kantar Health and Jay Grisolano, Ph.D.,... Read more
December 07, 2016